Magnetic Resonance Imaging in Predicting Pathological Response of Triple Negative Breast Cancer Following Neoadjuvant Chemotherapy-Reference-Cited by-同舟云学术

Magnetic Resonance Imaging in Predicting Pathological Response of Triple Negative Breast Cancer Following Neoadjuvant Chemotherapy

Published:2007-12-10 Issue:35 Volume:25 Page:5667-5669
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Chen Jeon-Hor¹,Mehta Rita S.²,Carpenter Philip M.³,Nalcioglu Orhan⁴,Su Min-Ying⁴

Affiliation:

1. Center for Functional Onco-Imaging, University of California, Irvine, CA; Department of Radiology, China Medical University Hospital, Taichung, Taiwan

2. Department of Medicine, University of California, Irvine, CA

3. Department of Pathology and Laboratory Medicine, University of California, Irvine, CA

4. Center for Functional Onco-Imaging, University of California, Irvine, CA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.14.6134

Reference15 articles.

1. Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

2. Prognostic markers in triple-negative breast cancer

3. Triple-negative breast cancer: therapeutic options

4. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

5. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic Resonance Imaging of the Breast in Surgical Planning;Oncoplastic and Reconstructive Breast Surgery;2019

2. Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapy;Critical Reviews in Oncology/Hematology;2018-12

3. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy;Clinical Breast Cancer;2018-10

4. Breast Cancer Subtype Influences the Accuracy of Predicting Pathologic Response by Imaging and Clinical Breast Exam After Neoadjuvant Chemotherapy;Anticancer Research;2016-10-12

5. Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy;Acta Radiologica;2015-09